Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today
November 17, 2014 at 08:31 AM EST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that IMPROVE-IT met its primary endpoint. The results ...